Search results
Results from the WOW.Com Content Network
"Providers are encouraged to consult with their local lab(s) to obtain hormone level reference ranges for both 'male' and 'female' norms, [which can vary,] and then apply the correct range when interpreting results based on the current hormonal sex, rather than the sex of registration." [3] Fenway Health: United States: 100–200 pg/mL <55 ng ...
Thinning/slowed growth of facial/body hair: 4–12 months >3 years [c] Reversible Cessation/reversal of male-pattern scalp hair loss: 1–3 months: 1–2 years [d] Reversible Softening of skin/decreased oiliness and acne: 3–6 months: Unknown: Reversible Redistribution of body fat in a feminine pattern: 3–6 months: 2–5 years: Reversible ...
5–20 mg every 2 wks Estradiol cypionate: Depo-Estradiol: Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol dipropionate: Agofollin: Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol benzoate: Progynon-B: Estrogen: IM, SC: 0.5–1.5 mg every 2–3 days Estriol: Ovestin [c] Estrogen: Oral: 4–6 mg/day ...
Body roundness index (BRI) is a calculated geometric index used to quantify an aspect of a person's individual body shape. Based on the principle of body eccentricity, it provides a rapid visual and anthropometric tool for health evaluation. [1] Introduced in 2013, the BRI calculation can be used to estimate total and visceral body fat.
[4] 5-ARIs are sometimes used as antiandrogens in feminizing hormone therapy for transgender women to help reduce body hair growth and scalp hair loss. [2] They have also been explored in the treatment and prevention of prostate cancer. While the 5-ARI finasteride reduces the cancer risk by about a third, it also increases the fraction of ...
Sizes generally range from 3–8 cm with 4–5 cm being about average. This is genetically determined, but some physicians advocate topical clitoral testosterone as an adjunct to growth before metoidioplasty. However, this testosterone is absorbed and should be calculated into one's total regimen.
Gynoid fat contributes toward the female body shape that girls begin to develop at puberty; it is stored in the hips, thighs and bottom. [7] This process is modulated by estrogen, the female sex hormone, causing the female form to store higher levels of fat than the male form, which is affected primarily by testosterone.
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.